Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur J Vasc Endovasc Surg. 2010 Apr;39(4):460-71. doi: 10.1016/j.ejvs.2009.12.014. Epub 2010 Mar 20.

Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease.

Author information

1
University of Birmingham, Department of Vascular Surgery, Heart of England NHS Foundation Trust, Netherwood House, Solihull Hospital, Birmingham, UK.

Abstract

BACKGROUND:

Aortofemoral bypass(AFB), iliofemoral bypass(IFB), and aortoiliac endarterectomy(AIE) are the three most common techniques for anatomical open surgical revascularisation for patients with aorto-iliac occlusive disease(AIOD), but the optimal method of reconstruction is unknown.

AIMS:

To review and compare mortality, morbidity and short- and long-term patency rates for AFB, IFB and AIE in patients with AIOD reported in the English language literature

METHODS:

A MEDLINE(1970-2007) and Cochrane Library search for articles relating to AFB, IFB, AIE and AIOD was undertaken. Studies were included if: a) patency rates based on life-tables were available, and b) patient/study characteristics were reported.

RESULTS:

29 studies(5738 patients) for AFB, 11 studies(778 patients) for IFB and 11 studies(1490 patients) for AIE were included. Operative mortality was 4.1% for AFB, 2.7% for IFB and 2.7% for AIE (p<0.0001). Systemic morbidity was 16.0% for AFB, 18.9% for IFB and 12.5% for AIE (p<0.05). Overall 5-year primary patency rates were 86.3%, 85.3% and 88.3% for AFB, IFB and AIE, respectively (p=NS).

CONCLUSION:

Aorto-iliac endarterectomy was associated with significantly lower peri-operative morbidity and mortality rates compared with bypass grafting. All three techniques were equally effective in terms of long-term patency.

PMID:
20303805
DOI:
10.1016/j.ejvs.2009.12.014
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center